Non-catecholamine vasopressors in the treatment of adult patients with septic shock—evidence from meta-analysis and trial sequential analysis of randomized clinical trials
Abstract Background Norepinephrine (NE) has currently been the first-choice vasopressor in treating septic shock despite generally insufficient for patients with refractory septic shock. The aim of this update meta-analysis was to assess the safety and efficacy of a combination of non-catecholamine...
Main Authors: | Lei Zhong, Xiao-Wei Ji, Hai-Li Wang, Guang-Ming Zhao, Qing Zhou, Bo Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Journal of Intensive Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40560-020-00500-0 |
Similar Items
-
Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis
by: Ren-qi Yao, et al.
Published: (2020-05-01) -
Broad spectrum vasopressors: a new approach to the initial management of septic shock?
by: Lakhmir S. Chawla, et al.
Published: (2019-04-01) -
Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS)
by: Kyeongman Jeon, et al.
Published: (2018-05-01) -
Comparative efficacy of vasoactive medications in patients with septic shock: a network meta-analysis of randomized controlled trials
by: Lu Cheng, et al.
Published: (2019-05-01) -
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
by: James A. Russell, et al.
Published: (2017-08-01)